In the complex landscape of mental health research, a new peer-reviewed Viewpoint review sheds light on an underexplored genetic player: the trace amine-associated receptor 1 (TAAR1). Published in Genomic Psychiatry (ISSN: 2997-2388, Genomic Press, New York), this thought-provoking analysis suggests that mutations in the TAAR1 gene may be a crucial piece of the puzzle in understanding and treating neuropsychiatric disorders.
Califf and Marks call for clinicians to help address ‘large volume’ of vaccine misinformation
FDA Commissioner Rob Califf and biologics director Peter Marks took to JAMA on Friday to counter the current “large volume” of vaccine misinformation by urging